Deazaneplanocin a is a promising drug to kill multiple myeloma cells in their niche

HIGHLIGHTS

• who: Jérémie Gaudichon and collaborators from the Villejuif, France, Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands have published the Article: Deazaneplanocin A Is a Promising Drug to Kill Multiple Myeloma Cells in Their Niche, in the Journal: PLOS ONE | www.plosone.org of September/25,/2014
• what: The authors show here that in some MM cell lines DZNep induced both caspase-dependent and -independent apoptosis. This model has been found pertinent for the evaluation of therapies in multiple myeloma . The authors show here that DZNep does not trigger the death . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.